Literature DB >> 16986176

Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training.

R F Brown1, P N Butow, F Boyle, M H N Tattersall.   

Abstract

INTRODUCTION: Clinical trials have come to be regarded as the gold standard for treatment evaluation. However, many doctors and their patients experience difficulties when discussing trial participation, leading to poor accrual to trials and questionable quality of informed consent. We have previously developed a communication skills training program based on a typology for ethical communication about Phase II and III clinical trials within four categories. The training program consisted of a 1 day experiential workshop that included didactic teaching, exemplary video and role play. The aim of this study was to evaluate the effectiveness of the communication skills training workshop.
METHOD: Oncologists were recruited from three major teaching hospitals conducting oncology outpatient clinics in three Australian capital cities. Ten oncologists and 90 of their adult cancer patients who were eligible for a Phase II or III clinical trial participated. Ninety informed consent consultations were audiotaped before (n = 59) and after (n = 31) training, and fully transcribed. The presence or absence of each domain component was coded and these were summed within categories. A coding manual was produced which enabled standardization of the coding procedure. Patients completed questionnaires before and after the consultation, and doctors completed a short measure of satisfaction after the consultation.
RESULTS: Doctors increased their use of some aspects of shared decision-making behavior (t(87) = -1.945, p = 0.05) and described some aspects of essential ethical/clinical information more commonly. In addition they used less coercive behaviors (z = -1.976, p = 0.048). However, they did not provide more clinical information or structure their consultations in the recommended fashion. Patients in the post-training cohort reported more positive attitudes to clinical trials, but other outcomes were not affected by the intervention.
CONCLUSIONS: This short training programme demonstrated limited success in improving the oncologist's communication skills when gaining informed consent. A larger randomized controlled trial of extended training is now underway. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2007        PMID: 16986176     DOI: 10.1002/pon.1095

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  32 in total

1.  "The promise of community-based advocacy and education efforts for increasing cancer clinical trials accrual".

Authors:  Margo Michaels; Elisa S Weiss; John A Guidry; Natasha Blakeney; Liz Swords; Brian Gibbs; Samantha Yeun; Bruce Rytkonen; Robert Goodman; S Lisbeth Jarama; Amanda L Greene; Shilpa Patel
Journal:  J Cancer Educ       Date:  2012-03       Impact factor: 2.037

2.  Toward a greater understanding of breast cancer patients' decisions to discuss cancer-related internet information with their doctors: an exploratory study.

Authors:  Thomas A D'Agostino; Jamie S Ostroff; Alexandra Heerdt; Maura Dickler; Yuelin Li; Carma L Bylund
Journal:  Patient Educ Couns       Date:  2012-06-19

3.  Parent participation and physician-parent communication during informed consent in child leukemia.

Authors:  Melissa Cousino; Rebecca Hazen; Amy Yamokoski; Victoria Miller; Stephen Zyzanski; Dennis Drotar; Eric Kodish
Journal:  Pediatrics       Date:  2011-11-07       Impact factor: 7.124

4.  Satisfaction with the decision to participate in cancer clinical trials is high, but understanding is a problem.

Authors:  M Jefford; L Mileshkin; J Matthews; H Raunow; C O'Kane; T Cavicchiolo; H Brasier; M Anderson; J Reynolds
Journal:  Support Care Cancer       Date:  2010-02-23       Impact factor: 3.603

5.  Sharing decisions in breast cancer care: Development of the Decision Analysis System for Oncology (DAS-O) to identify shared decision making during treatment consultations.

Authors:  Richard F Brown; Phyllis N Butow; Ilona Juraskova; Karin Ribi; Daniela Gerber; Jurg Bernhard; Martin H N Tattersall
Journal:  Health Expect       Date:  2011-03       Impact factor: 3.377

6.  Power of an effective clinical conversation: improving accrual onto clinical trials.

Authors:  Linda K Parreco; Rhonda W DeJoice; Holly A Massett; Rose Mary Padberg; Sona S Thakkar
Journal:  J Oncol Pract       Date:  2012-03-27       Impact factor: 3.840

7.  Testing the utility of a cancer clinical trial specific Question Prompt List (QPL-CT) during oncology consultations.

Authors:  Richard F Brown; Carma L Bylund; Yuelin Li; Shawna Edgerson; Phyllis Butow
Journal:  Patient Educ Couns       Date:  2012-03-04

8.  Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer.

Authors:  Lauren M Hamel; Louis A Penner; Terrance L Albrecht; Elisabeth Heath; Clement K Gwede; Susan Eggly
Journal:  Cancer Control       Date:  2016-10       Impact factor: 3.302

9.  Improving informed consent: pilot of a decision aid for women invited to participate in a breast cancer prevention trial (IBIS-II DCIS).

Authors:  I Juraskova; P Butow; A Lopez; M Seccombe; A Coates; F Boyle; N McCarthy; L Reaby; J F Forbes
Journal:  Health Expect       Date:  2008-09       Impact factor: 3.377

10.  Developing a Model of the Benefits and Burdens of Research Participation in Cancer Clinical Trials.

Authors:  Connie M Ulrich; Kathleen A Knafl; Sarah J Ratcliffe; Therese S Richmond; Christine Grady; Claiborne Miller-Davis; Gwenyth R Wallen
Journal:  AJOB Prim Res       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.